证据和现实:关于在高级头瘤中药理学结果的观察性研究
Consuelo Jordán de Luna1,2, Anna Esteve Gomez3, Olalla Montero Pérez1
1Pharmacy Department, Institut Català d'Oncologia-ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
Frontiers in oncology
|August 11, 2025
概括
本研究评估了使用真实数据对头癌治疗机构临床指导方针的有效性. 它分析了患者的结果,以评估这些个性化医学指南的实际实用性.
科学领域:
- 在瘤学瘤学.
- 临床实践指南 临床实践指南
- 个性化医疗是个性化的医疗.
背景情况:
- 加泰罗尼亚瘤研究所 (ICO) 使用机构临床实践指南 (ICOPraxis) 进行癌症护理.
- 瘤学正在向个性化医学转变,需要局部指导准确性.
- 评估指南的实用性需要分析治疗选择和患者的结果.
研究的目的:
- 评估ICOPraxis针对头癌的指导方针的实际实用性.
- 描述局部晚期和复发性/转移性头支状细胞癌 (HNSCC) 患者的治疗结果.
- 将现实世界的数据结果与临床试验结果进行比较.
主要方法:
- 追溯的队列分析.
- 包括被诊断为局部发达和复发/转移性HNSCC (III-IVc阶段) 的患者.
- 来自ICO和贝尔维特格大学医院头癌功能部门的治疗数据.
主要成果:
- 对治疗选择和患者结果的描述性分析.
- 现实世界的数据为机构指导方针的有效性提供了见解.
- 与临床试验相比,可能会观察到治疗效果的潜在稀释.
结论:
- 机构指导方针为个性化癌症护理提供了专注的方法.
- 现实世界的数据分析对于理解临床实践中指南的影响至关重要.
- 这项研究有助于完善头癌治疗策略.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.6K
12:03Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
19.4K
相关概念视频
Pharmacovigilance
993
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
993
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
